The utility of uterine artery doppler velocimetry in prediction of preeclampsia in a low-risk population

Obstetrics and Gynecology

Volumn 120, Issue 4, 2012, Pages 815-822

  Myatt, Leslie ^a   Clifton, Rebecca G ^b   Roberts, James M ^b   Spong, Catherine Y ^b   Hauth, John C ^b   Varner, Michael W ^b   Wapner, Ronald J ^b   Thorp, John M ^b   Mercer, Brian M ^b   Grobman, William A ^b   Ramin, Susan M ^b   Carpenter, Marshall W ^b   Samuels, Philip ^b   Sciscione, Anthony ^b   Harper, Margaret ^b   Tolosa, Jorge E ^b   Saade, George ^b   Sorokin, Yoram ^b   Anderson, Garland D ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIHYPERTENSIVE AGENT; ASCORBIC ACID;

ADULT; AFRICAN AMERICAN; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR PARAMETERS; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; HISPANIC; HUMAN; LASER DOPPLER FLOWMETRY; MAJOR CLINICAL STUDY; MATERNAL AGE; NULLIPARA; ONSET AGE; PLACENTA CIRCULATION; PREDICTIVE VALUE; PREECLAMPSIA; PRIORITY JOURNAL; PULSATILITY INDEX; RANDOMIZED CONTROLLED TRIAL; RESISTANCE INDEX; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; TROPHOBLAST; UTERINE ARTERY; VASCULAR RESISTANCE;

ADULT; BLOOD FLOW VELOCITY; COHORT STUDIES; FEMALE; HEMORHEOLOGY; HUMANS; ODDS RATIO; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PROGNOSIS; RISK; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, PRENATAL; UTERINE ARTERY;

EID: 84866888544     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31826af7fb     Document Type: Article

References (21)

1. World Health Organization. Estimates of maternal mortality: A new approach by WHO and UNICED. Geneva (Switzerland): World Health Organization; 1996.
2. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995;345: 1455-63.
3. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: Systematic review and meta-analysis. BMJ 2007;335:974.
4. McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/eclampsia: A systematic review and meta-analyses. Am Heart J 2008;156: 918-30.
5. Papageorghiou AT, Yu CK, Nicolaides KH. The role of uterine artery Doppler in predicting adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 2004;18:383-96.
6. Papageorghiou AT, Yu CK, Bindra R, Pandis G, Nicolaides KH. Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol 2001;18:441-9.
7. Roberts JM, Myatt L, Spong CY, Thom EA, Hauth JC, Leveno KJ, et al. Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med 2010;362: 1282-91.
8. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 1988;44: 837-45.
9. Martin AM, Bindra R, Curcio P, Cicero S, Nicolaides KH. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation. Ultrasound Obstet Gynecol 2001;18:583-6.
10. Parra M, Rodrigo R, Barja P, Bosco C, Fernandez V, Munoz H, et al. Screening test for pre-eclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction. Am J Obstet Gynecol 2005;193:1486-91.
11. Papageorghiou AT. Predicting and preventing pre-eclampsiawhere to next? Ultrasound Obstet Gynecol 2008;31:367-70.
12. Campbell S, Diaz-Recasens J, Griffin DR, Cohen-Overbeek TE, Pearce JM, Willson K, et al. New Doppler technique for assessing uteroplacental blood flow. Lancet 1983;1:675-7.
13. Plasencia W, Maiz N, Poon L, Yu C, Nicolaides KH. Uterine artery Doppler at 11-0 to 13-6 weeks and 21-0 to 24-6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 2008;32:138-46.
14. Bower S, Bewley S, Campbell S. Improved prediction of preeclampsia by two-stage screening of uterine arteries using the early diastolic notch and color Doppler imaging. Obstet Gynecol 1993;82:78-83.
15. Cnossen JS, Morris RK, ter Riet G, Mol BW, van der Post JA, Coomarasamy A, et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: A systematic review and bivariable meta-analysis. CMAJ 2008;178:701-11.
16. Fleischer A, Schulman H, Farmakides G, Bracero L, Grunfeld L, Rochelson B, et al. Uterine artery Doppler velocimetry in pregnant women with hypertension. Am J Obstet Gynecol 1986;154:806-13
17. Roberts JM, Hubel CA. The two stage model of preeclampsia: Variations on the theme. Placenta 2009;30:S32-7.
18. Myatt L, Carpenter L. Prediction of pre-eclampsia. In: Lyall F, Belfort M, editors. Pre-eclampsia: Etiology and clinical practice. Cambridge (MA): Cambridge University Press; 2007.
19. Roberts JM, Catov JM. Preeclampsia more than 1 disease: Or is it? Hypertension 2008;51:989-90.
20. Giguere Y, Charland M, Bujold E, Bernard N, Grenier S, Rousseau F, et al. Combining biochemical and ultrasonographic markers in predicting preeclampsia: A systematic review. Clin Chem 2010;56:361-75.
21. Myatt L, Clifton RG, Roberts JM, Spong CY, Hauth JC, Varner MW, et al. First-trimester prediction of preeclampsia in nulliparous women at low risk. Obstet Gynecol 2012;119: 1234-42.